Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Antonio Saverio Roscini"'
Publikováno v:
AboutOpen, Vol 10, Iss 1 (2023)
Background: The aim of this economic evaluation was to compare the cost per responder between vedolizumab and ustekinumab in patients with Crohn’s disease (CD) after failure of tumor necrosis factor-α inhibitors in Italy. Methods: Clinical effica
Externí odkaz:
https://doaj.org/article/00f6771f147c4d7783b41dd30ef415f4
Autor:
Loreta A. Kondili, Massimo Andreoni, Alfredo Alberti, Salvatore Lobello, Sergio Babudieri, Antonio Saverio Roscini, Rocco Merolla, Walter Marrocco, Antonio Craxì
Publikováno v:
Epidemics, Vol 34, Iss , Pp 100442- (2021)
Background: The universal treatment of diagnosed patients with chronic HCV infection has been widely conducted in Italy since 2017. However, the pool of individuals diagnosed but yet to be treated in Italy has been estimated to end around 2025, leavi
Externí odkaz:
https://doaj.org/article/9d7e97f44aac4351891c5ddf53a9fba0
Autor:
Antonio Craxì, Sergio Babudieri, Alfredo Alberti, Walter Marrocco, Rocco Cosimo Damiano Merolla, Salvatore Lobello, Massimo Andreoni, Antonio Saverio Roscini, Loreta A. Kondili
Publikováno v:
Epidemics, Vol 34, Iss, Pp 100442-(2021)
Background The universal treatment of diagnosed patients with chronic HCV infection has been widely conducted in Italy since 2017. However, the pool of individuals diagnosed but yet to be treated in Italy has been estimated to end around 2025, leavin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f9530461a75d23af76e6b3f781dbc1
http://hdl.handle.net/10447/535590
http://hdl.handle.net/10447/535590
